Hexarelin 5 mg
Educational recon guide for a 5 mg Hexarelin research vial and microgram pulse unit mapping. Research use only.
Vial size
Same research phases — calculator defaults and unit math match the selected vial strength.
Vial
5 mg
Your BAC water
2 mL
Concentration
2.50 mg/mL
Per unit
~25.0 mcg
Frequency
1–3× daily subcutaneous (often shorter cycles than milder GHRPs due to desensitization discussions)
Route
Subcutaneous
Live reconstitution calculator
Defaults match this guide (5 mg + 2 mL BAC). Change water or dose and the unit tables below update automatically.
Step 1
Reconstitution
Peptide amount in the vial and how much bacteriostatic water you add.
Step 2
Your dose
This guide uses microgram-scale research doses — quick picks are in mcg (100 mcg = 0.1 mg).
Quick select (mcg) — switch units or type any value
Suggested: 30-unit barrel (smallest that fits this draw).
Your draw
Results
Total draw
4 units
Volume
0.040 mL
Doses per vial
50
Syringes needed
1
Barrel
30-unit
Fits one syringe?
Yes
30-unit · 0.3 mL
Filled to 4 u
Fill one 30-unit U-100 syringe to about 4 units (0.040 mL).
Research cycle phases
Units and volumes recompute from your Step 1 concentration (2 mL BAC → 2.50 mg/mL · 25.0 mcg/unit). Doses below are once daily during the course — not weekly.
Standard course
Human IV rising-dose work used ~0.5–2 mcg/kg; community SC educational tables commonly use ~100–200 mcg per injection, 1–3× daily. Hexarelin is among the stronger GHRPs — cortisol/prolactin elevation and receptor desensitization are frequently discussed.
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Days 1–14 (intro) | 100 mcg0.1 mg | 4 u | 0.04 mL100 mcg per injection |
| Days 15–42 (standard) | 200 mcg0.2 mg | 8 u | 0.08 mL200 mcg per injection |
Alternate / higher courses
Shorter or higher daily courses discussed in research communities — not a clinical recommendation
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Higher pulse · 300 mcg | 300 mcg0.3 mg | 12 u | 0.12 mLUpper common range — watch desensitization / side-effect discussions |
Supplies planner
Using the guide’s phase ladder (100 mcg → 200 mcg per injection (phase ladder)) over a 42-day course. Set a dose in Step 2 to plan supplies at your own amount.
Your recon
2 mL · 2.50 mg/mL
Dose in plan
Phase ladder
Syringe size
100-unit
Horizon
42-day course
Hexarelin 5 mg vials
2 vials
~7 mg mg total peptide over this 42-day course at 100 mcg → 200 mcg per injection (phase ladder). Each vial holds 5 mg.
Bacteriostatic water
2 × 3 mL or 1 × 10 mL
2 mL BAC per vial × 2 vials = 4.0 mL total. Buy as 2× 3 mL bottles or 1× 10 mL bottle (whichever you stock).
U-100 insulin syringes (100-unit)
42+ syringes
About one 100-unit syringe per injection for this schedule. Keep a few spares.
Alcohol swabs & sharps
~88 swabs · 1 sharps container
Wipe vial stopper and injection site each time. Dispose needles in a proper sharps container.
Reconstitution steps
- Allow the lyophilized 5 mg Hexarelin vial and bacteriostatic water to reach room temperature.
- Draw 2.0 mL bacteriostatic water (default for this guide).
- Inject BAC slowly down the inner wall of the vial — avoid blasting the powder cake.
- Gently swirl or roll until the solution is clear. Do not shake hard (foaming).
- Label with recon date and concentration (e.g. "2.5 mg/mL — 2 mL BAC").
- Refrigerate at 2–8 °C (35–46 °F), protected from light. Prefer using a reconstituted multi-dose vial within ~28 days with sterile technique.
Storage
Lyophilized
Keep dry powder cold and dark when possible (−20 °C / −4 °F preferred for long-term research stock).
Reconstituted
Refrigerate at 2–8 °C (35–46 °F). Avoid freeze–thaw of the working solution. Prefer finishing within ~28 days.
- ·Write recon date and BAC volume on the label.
- ·Protect from light during storage.
- ·Discard if cloudy, particulates, or odd odor appear after reconstitution.
Protocol notes
- ·Hexarelin is a potent GHRP-class secretagogue.
- ·Calculator: 0.1 mg = 100 mcg.
- ·Often cycled shorter than milder GHRPs in community write-ups.
- ·Research use only.
Research context & considerations
Hexarelin has human experimental data for GH release and additional research interest (including cardiac models). Research vials are not approved GH therapies.
- ·Cortisol/prolactin elevation, water retention, desensitization with continuous use.
- ·GH-axis malignancy and metabolic cautions apply.
- ·Not FDA-approved as a research-vial product.
- ·Pregnancy out of scope.
Catalog match
Hexarelin Acetate (HX5)
5mg x 10 vials · from $30